Jubilant Pharmova Limited (BOM: 530019)
India
· Delayed Price · Currency is INR
942.80
-41.05 (-4.17%)
At close: Jan 21, 2025
Jubilant Pharmova Revenue
Jubilant Pharmova had revenue of 17.52B INR in the quarter ending September 30, 2024, with 4.28% growth. This brings the company's revenue in the last twelve months to 69.20B, up 6.49% year-over-year. In the fiscal year ending March 31, 2024, Jubilant Pharmova had annual revenue of 67.03B with 6.71% growth.
Revenue (ttm)
69.20B
Revenue Growth
+6.49%
P/S Ratio
2.16
Revenue / Employee
12.82M
Employees
5,399
Market Cap
149.29B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 67.03B | 4.21B | 6.71% |
Mar 31, 2023 | 62.82B | 1.52B | 2.47% |
Mar 31, 2022 | 61.30B | 316.29M | 0.52% |
Mar 31, 2021 | 60.99B | 1.23B | 2.05% |
Mar 31, 2020 | 59.76B | -31.35B | -34.41% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
Tata Consultancy Services | 2,520.82B |
HDFC Bank | 2,761.06B |
Bharti Airtel | 1,554.78B |
ICICI Bank | 1,638.51B |
Infosys | 1,635.60B |
State Bank of India | 3,360.28B |
ITC Limited | 751.35B |
Jubilant Pharmova News
- 5 weeks ago - Jubilant to buy 40% in Coke bottler's parent for 10k cr - The Times of India
- 7 weeks ago - Bernstein maintains Outperform rating on Jubilant Foodworks, highlights three pillars to achieve $10 billion market cap - Business Upturn
- 2 months ago - Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer - Benzinga
- 2 months ago - CLSA maintains ‘Underperform’ rating on Jubilant FoodWorks with target price of Rs 445, expecting 26% downside - Business Upturn
- 2 months ago - Jefferies maintains ‘Buy’ rating on Jubilant FoodWorks with target price of Rs 880, expecting 46% upside - Business Upturn
- 2 months ago - Morgan Stanley maintains ‘Equal-weight’ rating on Jubilant FoodWorks with target price of Rs 620 - Business Upturn
- 4 months ago - Stocks to Watch: RIL, Adani Enterprises, BEL, GAIL, Kaynes Technology, Lupin, Jubilant Pharma, Zomato and morein focus today (Sept 30, 2024) - Business Upturn